Use the Back button in your browser to see the other results of your search or to select another record.
The role of transcutaneous electrical stimulation of Neiguan anti-emetic acupuncture point in controlling sickness after cancer chemotherapy |
McMillan C, Dundee JW |
Physiotherapy 1991 Jul;77(7):499-502 |
clinical trial |
1/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: No; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: No; Point estimates and variability: No. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
The already proven anti-emetic action of P6 (Neiguan) acupuncture has been used with success in patients having cancer chemotherapy. The more patient-acceptable alternative to needling, transcutaneous electrical stimulation of P6, has been evaluated using a simple, custom-built stimulator and large surface electrodes. This can be administered by the patient and preliminary findings show it to be a useful adjunct to both the older anti-emetics and the new 5 HT3 antagonist, ondansetron.
|